R

Redcare Pharmacy

Online pharmacy selling prescription meds

Senior Financial Planning and Analysis Analyst / Finance Business Partner

Full-TimeUpdated on 10/14/2026
No salary listed
Mid, Senior
Bachelor's, Master's
Sevenum, Netherlands
Hybrid
Finance & BankingCorporate Finance & FP&A

About the job

Requirements
  • Hold a bachelor's or master's degree in Finance, Economics, Business Administration, Accounting, or a related discipline.
  • Have approximately four to six years of experience in FP&A, business controlling, financial analysis, or a comparable role.
  • Have a strong understanding of financial planning, forecasting, performance management, and business-case development.
  • Have solid financial-modelling skills and be able to turn complex data into practical insights and recommendations.
  • Be highly proficient in Excel and have experience with analytical tools such as Power Query, Power Pivot, or similar solutions.
  • Communicate confidently and build effective relationships with senior stakeholders, cross-functional colleagues, and international teams.
  • Be curious, proactive, and comfortable constructively challenging established assumptions.
  • Continuously look for opportunities to improve processes through technology, automation, and AI.
Responsibilities
  • Coordinate and continuously improve Group-wide financial planning and forecasting processes.
  • Own the planning, forecasting, reporting, and performance-management cycles for Human Resources and Pharma Operations.
  • Prepare monthly performance analyses, variance reports, and management presentations.
  • Coordinate Group-level Human Resources reporting, including headcount and personnel-cost analysis.
  • Analyse financial performance, operational key performance indicators, and key cost drivers to identify risks, opportunities, and areas for improvement.
  • Improve forecasting accuracy, planning methodologies, and financial transparency.
  • Use Pigment, automation, and AI-driven solutions to improve FP&A process efficiency and effectiveness.
  • Act as a trusted finance partner to the Head of Human Resources, the Head of Pharma Operations, and their leadership teams.
  • Challenge assumptions and provide evidence-based recommendations to support business decisions.
  • Identify financial risks and opportunities and help stakeholders translate them into concrete actions.
  • Develop and evaluate business cases for strategic investments, transformation programmes, and growth initiatives.
  • Build scenario models and financial-impact assessments to support key decisions.
  • Communicate complex financial topics to financial and non-financial stakeholders.
Desired Qualifications
  • Experience with Pigment or another enterprise planning platform is an advantage.

About the company

Redcare Pharmacy runs an online European pharmacy that sells prescription and over-the-counter medicines, health supplements, and beauty/personal care items directly to customers. It uses a web-based e-commerce platform, bypassing physical pharmacies, and has integrated digital health tools (such as MyTherapy and Dutch e-health platforms) and electronic prescriptions to streamline ordering and medication management. The company differentiates itself by expanding through acquisitions (e.g., Europa Apotheek, nu3) to grow prescription drug sales and digital health offerings, while focusing on the DACH region and maintaining a catalog of 150,000+ products. Its goal is to provide convenient, affordable access to medicines and health products across Europe via a scalable online platform.

Company Size

51-200

Company Stage

IPO

Headquarters

Venlo, Netherlands

Founded

2001

Get referred to Redcare Pharmacy

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue grew 20%, and adjusted EBITDA margin hit 3.5%.
  • June 2026 active customers reached 14.7 million, up 9% year over year.
  • Germany's Fixum rises July 1, 2026 and again January 1, 2027.

What critics are saying

  • Rossmann plans an online pharmacy from the Netherlands, directly attacking Redcare's home turf.
  • Redcare cut 2026 OTC growth to 8%-10% as dm and Rossmann intensify pricing.
  • A failed Germany Rx turnaround leaves Redcare trapped in low-margin OTC retail.

What makes Redcare Pharmacy unique

  • Redcare led German e-prescriptions first, reaching 1.7 million Rx customers by June 2026.
  • Seven-country platform and 250,000 products create scale unavailable to local pharmacies.
  • MyTherapy, MedApp, and app-based ordering deepen retention beyond commodity OTC shopping.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options
  • Paid Vacation
  • Employee Discount
  • Training Programs
  • Commuter Benefits
  • Employee Referral Bonus

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

-26%

2 year growth

2%
Yahoo Finance
Jul 30th, 2026
Redcare Pharmacy raises 2026 revenue growth guidance to 15-17% amid RX customer surge

Redcare Pharmacy NV raised its 2026 revenue growth guidance to 15-17%, up from the previous 13-15%. The online pharmacy reported reaching 1.7 million active prescription customers in Germany, representing 4% quarter-over-quarter growth. The company's adjusted EBITDA margin improved to 3.5% in Q2, its highest level in a decade. This was achieved whilst reducing marketing spending, demonstrating improved cost efficiency. However, the German non-prescription business experienced growth deceleration, partly attributed to a heatwave and competitive pressures. July trading was softer than expected, with anticipated group growth below 20%. CEO Olaf Heinrich addressed concerns about competitor Rossmann entering the online pharmacy market, noting that previous entrant DM had limited impact. He emphasised the complexity of the prescription segment as a barrier to new competitors. A new regulation requiring personal signatures for prescription deliveries will add minimal costs, expected to be less than £1 million annually. The company was not cash flow positive in Q2 despite improved profitability.

EQS Group
Dec 22nd, 2025
Redcare Pharmacy: Redemption of 2021/2028 convertible bond. | Corporate - EQS News

Redcare Pharmacy N.V. / Key word(s): Bond Redcare Pharmacy: Redemption of 2021/2028 convertible bond. 19.12.2025 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement.

TradingView
Dec 19th, 2025
Redcare Pharmacy bondholders to redeem €64.5M convertible bonds on 21 January 2026

Redcare Pharmacy has announced that bondholders will redeem €64.5 million of its convertible bonds on 21 January 2026. Following this transaction, the remaining nominal amount of the 2021/2028 convertible bond will be €2.6 million.

Shop Apotheke Europe
May 11th, 2023
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland. | SHOP APOTHEKE EUROPE

SHOP APOTHEKE EUROPE will acquire 51% of the shares of Mediservice AG, while Galenica AG will hold 49% of the joint venture.

Shop Apotheke Europe
Mar 15th, 2023
SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO. | SHOP APOTHEKE EUROPE

The Supervisory Board of SHOP APOTHEKE EUROPE has appointed Olaf Heinrich as new CEO as of 1 August 2023, subject to approval by the AGM.